Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-04-03 to 2025-05-05
Current total value of award: $308.27
Description: 8511295315!HEPATITIS B VIRUS V